Phase 4 N=33 Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome
Stable Angina · Metabolic Syndrome
Primary: Impact of Ranolazine on Hemoglobin A1C — -5; 2.6 percent change
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=313 Evaluation of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
Acute Bacterial Skin and Skin Structure Infections
Primary: Hospital Admission Rate at Initial Episode of Care — 60; 27; 96; 126 Participants — p=<0.001
Phase 4 N=19 Stereotactic Body Radiotherapy for Head and Neck Tumors
Squamous Cell Carcinoma of the Head and Neck · Nasopharyngeal Carcinoma · Salivary Gland Cancer
Primary: Local Control Rate — 1; 5 Participants
Phase 4 N=1,060 Enhanced Safety Surveillance of GlaxoSmithKline's (GSK's) Quadrivalent Seasonal Influenza Vaccines During the 2018/19 Influenza Season
Influenza, Human
Primary: Cumulative Percentage of Subjects Reporting Any Adverse Events of Interest (AEIs) and/or Adverse Events (AEs) Using Adverse Drug Reaction (ADR) Card, Post Dose 1 by…
Phase 4 N=79 Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery
Cholecystitis · Endometriosis · Bowel Obstruction
Primary: Peak Airway Pressures — 25.5; 28.3; 28; 30 cm H2O — p=0.01
Phase 4 N=52 Early Sodium Intake in Preterm Newborns
Hyponatremia · Premature
Primary: Hyponatremia — 6; 1 Participants — p=0.71
Phase 4 N=70 Cannabinoids for Pain Control During Medical Abortion
Medical Abortion · Pain
Primary: Maximum Self-reported Pain Score on a Numeric Rating Scale — 7; 7 score on a scale
Phase 4 N=30 A Study of Ivabradine in African-American/ Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction.
Heart Failure (HF)
Primary: Change From Baseline in Heart Rate (HR) at Day 57 — -9.5 beats per minute — p=0.013
Phase 4 N=56 Impact of Strattera and Behavior Therapy on the Home and School Functioning of Children With ADHD
Attention Deficit Hyperactivity Disorder
Primary: Rule Violations During Direct Classroom Observation at Endpoint (Week 8) — 6.15; 4.93 number occurences per 30 mins — p=<.05
Phase 4 N=46 Evaluation of Systane Complete for the Treatment of Contact Lens Discomfort
Contact Lens Discomfort · Dry Eye
Primary: Contact Lens Symptoms — 20.41; 18.92; 12.86; 17.92 Score on a Scale
Phase 4 N=32 Intravenous Lidocaine Versus Morphine for Severe Pain in the ED
Pain
Primary: Pain Score (NRS 0-10) — 5.1; 4.2 units on a scale
Phase 4 N=60 Management of Sub-Clinical Bacteriuria in Pregnancy
Cystitis · Cystitis;Puerperium · Pyelonephritis
Primary: Number of Participants Who Have Cystitis — 4; 4 Participants
Phase 4 N=8 Tear Osmolarity Changes After Instilling Isotonic Hyaluronate Artificial Tears
Dry Eye
Primary: Osmolarity Change From Baseline (mOsms/L) as a Function of Time (Minutes) — -0.94; 7.25; 5.31; -4.25 mOsmols/L — p=0.4
Phase 4 N=184 Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza
Influenza
Primary: Percentage of Patients With Recovery/Improvement in Health Status. — 2; 3; 2; 3 Participants — p=<0.0001
Phase 4 N=30 Transepicardial With Transseptal Autologous CD 133+ Bone Marrow Cell Implantation in Patient Following CABG Surgery
Coronary Artery Disease
Primary: Myocardial Defect Perfusion — 15.76; 15.38; 2.08; 3.85 Percentage of Myocardial Perfusion